vimarsana.com

Page 143 - முக்கிய வார்த்தைகள் ஸ்டுடியோக்கள் ப்ல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Drax to Acquire Pinnacle Renewable Energy – a Major Canada-Based International Supplier of Sustainable Biomass Fuel

Drax to Acquire Pinnacle Renewable Energy – a Major Canada-Based International Supplier of Sustainable Biomass Fuel Inbound investment signals a vote of confidence in Pinnacle’s expertise in sustainable wood pellet production in Canada and the Southern US Combination positioned as the world’s leading sustainable biomass generation and supply business /EIN News/ SELBY, United Kingdom, Feb. 08, 2021 (GLOBE NEWSWIRE) British energy company Drax has agreed to acquire Pinnacle at a price of C$11.30 per share, valuing Pinnacle at C$385 million. The acquisition brings together Drax, which owns the world’s largest sustainable biomass power station in the UK, with Pinnacle, one of the leading global producers of high-quality compressed wood pellets. This Canadian-UK combination will be positioned as the world’s leading sustainable biomass supply and power generation business.

Traffic update: Expect long delays as holidaymakers head home

MagForce AG: MagForce USA, Inc Announces Completion of Patient Treatment in Stage 2a of Pivotal U S Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

DGAP-Ad-hoc: MagForce AG / Key word(s): Study MagForce AG: MagForce USA, Inc. Announces Completion of Patient Treatment in Stage 2a of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System 08-Feb-2021 / 12:12 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure of an insider information acc. to Article 17 MAR of the Regulation (EU) No 596/2014 MagForce AG: MagForce USA, Inc. Announces Completion of Patient Treatment in Stage 2a of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.